Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 M and MGU in Placebo and Pioglitazone Groups at Baseline and After Treatment
After treatment, significant increases in whole body glucose disposal (M) and myocardial glucose utilization (MGU) were obtained only in the pioglitazone group. Error bars indicate SEM. *p < 0.05 for treatment differences between the placebo and pioglitazone groups.
|
